Data / Drug companies / Oxybutynin chloride
Oxybutynin chloride: 45 companies and 105 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Oxybutynin chloride is listed in the FDA National Drug Code Directory by 45 companies, with 105 products in commercial distribution. 105 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet; syrup, and the newest product started marketing on July 28, 2026.
The request: Get every company that lists oxybutynin chloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 45
- Products
- 105
- Generic (ANDA) products
- 105 (100.0%)
- Application numbers
- 18
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list oxybutynin chloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 11 | tablet; tablet, extended release | Generic drugs (ANDA) | April 27, 2026 |
| Rising Pharma Holdings, Inc. | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | July 21, 2026 |
| Bryant Ranch Prepack | 6 | tablet; tablet, extended release | Generic drugs (ANDA) | February 28, 2019 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet, extended release; tablet | Generic drugs (ANDA) | March 9, 2016 |
| AvKARE | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | May 1, 2025 |
| Chartwell RX, LLC | 4 | tablet, extended release; solution | Generic drugs (ANDA) | March 1, 2009 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | February 1, 2018 |
| Accord Healthcare Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | December 20, 2016 |
| Advagen Pharma Ltd | 3 | tablet, extended release | Generic drugs (ANDA) | October 27, 2020 |
| Ajanta Pharma USA Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | February 28, 2019 |
| Amneal Pharmaceuticals LLC | 3 | tablet, extended release | Generic drugs (ANDA) | November 2, 2015 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet | Generic drugs (ANDA) | September 30, 2022 |
| AvPAK | 3 | tablet, extended release | Generic drugs (ANDA) | May 25, 2012 |
| Coupler LLC | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | July 6, 2026 |
| Direct_Rx | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | November 11, 2020 |
| Lannett Company, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 1, 2009 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | December 22, 2017 |
| Strides Pharma Science Limited | 3 | tablet | Generic drugs (ANDA) | April 10, 2026 |
| American Health Packaging | 2 | tablet, extended release | Generic drugs (ANDA) | December 12, 2012 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | June 1, 2026 |
| Major Pharmaceuticals | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | November 15, 2017 |
| TruPharma, LLC | 2 | tablet | Generic drugs (ANDA) | July 28, 2026 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | April 16, 2026 |
| Ani Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2017 |
| Atlantic Biologicals Corp. | 1 | syrup | Generic drugs (ANDA) | March 29, 1996 |
| Bryant Ranch Prepack | 1 | tablet, extended release | Generic drugs (ANDA) | December 14, 2016 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | October 21, 2024 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | January 29, 1999 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | October 23, 2017 |
| KVK-Tech, Inc. | 1 | tablet | Generic drugs (ANDA) | December 22, 2017 |
| Lannett Company, Inc. | 1 | syrup | Generic drugs (ANDA) | March 29, 1996 |
| Leading Pharma, LLC | 1 | tablet | Generic drugs (ANDA) | November 1, 2019 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | November 1, 2019 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | February 19, 2024 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | August 9, 2022 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2017 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | February 11, 2022 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | December 20, 2016 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | September 27, 2016 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | November 1, 2019 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | March 26, 2020 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| Upsher-Smith Laboratories, LLC | 1 | tablet | Generic drugs (ANDA) | November 7, 2011 |
| Verityrx, LLC | 1 | tablet | Generic drugs (ANDA) | November 15, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 51 | 48.6% |
| Tablet | 50 | 47.6% |
| Syrup | 2 | 1.9% |
| Solution | 2 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 105 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Cholinergic Muscarinic Antagonist | 105 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.